Título : |
Treatment of aggressive pituitary adenomas and carcinomas-An overview |
Tipo de documento : |
documento electrónico |
Autores : |
Luis Vicente Syro Moreno, |
Fecha de publicación : |
2012 |
Títulos uniformes : |
US Endocrinology
|
Idioma : |
Inglés (eng) |
Palabras clave : |
Pituitary adenoma pituitary carcinoma O6-methylguanine-DNA methyltransferase (MGMT) temozolomide everolimus bevacizumab |
Resumen : |
Most pituitary tumors are non-invasive, benign adenomas that remain confined to the sella turcica. Some of them recur, have a rapid growth rate, and invade surrounding tissues. These adenomas, considered aggressive pituitary tumors, are difficult to manage and present problems due to incomplete resection. A pituitary carcinoma is diagnosed when craniospinal and/or systemic metastases are documented. Treatment options for pituitary adenomas are surgery, radiation, and drugs. Recent publications report the efficacy of temozolomide in the treatment of aggressive pituitary adenomas and carcinomas. Indications for, results with, and side effects of temozolomide therapy in aggressive pituitary tumors and pituitary carcinomas are reviewed here. Alternative treatment options for resistant or recurrent pituitary tumors are also discussed. |
Mención de responsabilidad : |
Luis V Syro, Leon D Ortiz, Fabio Rotondo, Humberto Uribe, Luis C Penagos, Eva Horvath, Kalman Kovacs |
DOI (Digital Object Identifier) : |
10.17925/USE.2012.08.01.50 |
En línea : |
https://www.touchendocrinology.com/treatment-of-aggressive-pituitary-adenomas-an [...] |
Enlace permanente : |
https://hospitalpablotobon.cloudbiteca.com/pmb/opac_css/index.php?lvl=notice_display&id=4505 |
Treatment of aggressive pituitary adenomas and carcinomas-An overview [documento electrónico] / Luis Vicente Syro Moreno, . - 2012. Obra : US EndocrinologyIdioma : Inglés ( eng) Palabras clave : |
Pituitary adenoma pituitary carcinoma O6-methylguanine-DNA methyltransferase (MGMT) temozolomide everolimus bevacizumab |
Resumen : |
Most pituitary tumors are non-invasive, benign adenomas that remain confined to the sella turcica. Some of them recur, have a rapid growth rate, and invade surrounding tissues. These adenomas, considered aggressive pituitary tumors, are difficult to manage and present problems due to incomplete resection. A pituitary carcinoma is diagnosed when craniospinal and/or systemic metastases are documented. Treatment options for pituitary adenomas are surgery, radiation, and drugs. Recent publications report the efficacy of temozolomide in the treatment of aggressive pituitary adenomas and carcinomas. Indications for, results with, and side effects of temozolomide therapy in aggressive pituitary tumors and pituitary carcinomas are reviewed here. Alternative treatment options for resistant or recurrent pituitary tumors are also discussed. |
Mención de responsabilidad : |
Luis V Syro, Leon D Ortiz, Fabio Rotondo, Humberto Uribe, Luis C Penagos, Eva Horvath, Kalman Kovacs |
DOI (Digital Object Identifier) : |
10.17925/USE.2012.08.01.50 |
En línea : |
https://www.touchendocrinology.com/treatment-of-aggressive-pituitary-adenomas-an [...] |
Enlace permanente : |
https://hospitalpablotobon.cloudbiteca.com/pmb/opac_css/index.php?lvl=notice_display&id=4505 |
| |